Medical research can take years to move from a laboratory finding to a treatment, screening program or change in clinical practice. Public funding decisions therefore matter not only to researchers but to patients, families and health services waiting for better options.
The Australian Medical Research Advisory Board has released a new strategy and priorities to guide investments from the Medical Research Future Fund. The fund supports research intended to improve health and wellbeing, and the published priorities help signal which questions may receive attention in future funding rounds.
Research funding is not a guarantee that a particular treatment will be developed. Studies can produce positive findings, mixed results or evidence that an approach does not work. That is part of responsible science. Strong research systems also need transparent methods, ethical oversight, diverse participants and the ability to reproduce results.
Why translation matters
For communities, the value of research is measured partly by whether discoveries can be implemented fairly. A promising intervention may have little impact if it is unaffordable, unavailable outside major cities or difficult for people with disability or language barriers to access.
Universities, hospitals, researchers, industry and governments each have a role in moving evidence into practice. Patients and community organisations should also be involved in shaping research questions, especially when the outcomes affect groups that have historically been under-represented.
Public investment should be judged over time by the quality of evidence it produces and whether that evidence improves care. The next step after announcing priorities is to demonstrate how funded research reaches the people it is meant to help.
Read more: Department of Health: Medical Research Future Fund updates; Medical Research Future Fund.
This article is general information, not medical advice.
